Abscisic acid (ABA) is a ubiquitous hormone that regulates plant growth, development and responses to environmental stresses. Its action is mediated by the PYR/PYL/RCAR family of START proteins, but it remains unclear how these receptors bind ABA and, in turn, how hormone binding leads to inhibition of the downstream type 2C protein phosphatase (PP2C) effectors. Here we report crystal structures of apo and ABA-bound receptors as well as a ternary PYL2-ABA-PP2C complex. The apo receptors contain an open ligand-binding pocket flanked by a gate that closes in response to ABA by way of conformational changes in two highly conserved b-loops that serve as a gate and latch. Moreover, ABA-induced closure of the gate creates a surface that enables the receptor to dock into and competitively inhibit the PP2C active site. A conserved tryptophan in the PP2C inserts directly between the gate and latch, which functions to further lock the receptor in a closed conformation. Together, our results identify a conserved gate-latch-lock mechanism underlying ABA signalling.
Abscisic acid is a vital hormone used by plants in their responses to environmental stresses, such as drought, cold and salinity. Genetic studies have established a canonical signalling pathway mediated by PP2Cs and subfamily 2 of SNF1-related kinases (SnRK2 kinases), which act downstream of ABA sensing 1-5 . However, identification of bona fide ABA receptors has been a daunting task, full of controversy and frustration 6 . A new class of START protein receptors called the PYR/PYL/RCARs has recently been described [7] [8] [9] . ABA binding to members of this protein family enables them to bind to and inhibit PP2Cs such as HAB1, leading to the activation of the SnRK2 kinases that phosphorylate downstream effectors, such as the basic leucinezipper transcription factors called ABFs/AREBs, thus switching on stress response programs 1, [10] [11] [12] [13] . The mechanisms of ABA binding and PP2C inhibition by the PYR/PYL/RCARs are currently unknown. In addition, the binding of ABA to RCAR1 (PYL9) and PYL5 is stimulated .10 fold by the presence of a PP2C, and many of the PYR/PYL/ RCAR proteins show constitutive (that is, unliganded) binding to PP2Cs 7, 8 . These observations have led to an important but currently unresolved question: does ABA bind to a PYR/PYL/RCAR-PP2C coreceptor, or does ABA bind first to the PYR/PYL/RCAR receptors followed by secondary PP2C interactions that stabilize ligand binding? Many of the most critical questions regarding how ABA receptors function will require structural elucidation of ligand-bound and ligand-free receptors, and a receptor-PP2C complex. Here we report the crystal structures of apo-and ABA-bound forms of PYL2, and the ABA-PYL2-HAB1 complex at resolutions of 1.95 Å , 1.85 Å and 1.95 Å , respectively, as well as the apo-PYL1 structure at a resolution of 2.40 Å . Comparison of the apo-and ABA-bound structures shows that ABA binding induces closure of two highly conserved b-loops that function as a gate and latch to sense ligand entry. In the apo form of the receptor, the gate and latch reside in an open conformation, which permits access of ABA to the ligand-binding pocket. ABA binding induces the closure of the gate and formation of a gate/latch interface, which in turn binds to the PP2C active site and converts the ABA-bound PYL2 into a competitive PP2C inhibitor. The interactions between PYL2 and HAB1 further induce conformational changes in both proteins that lock the gate into the closed position, which is primarily mediated by a conserved tryptophan of HAB1. Importantly, this residue also makes a water-mediated interaction with ABA, thus allowing HAB1 to sense the presence of ABA in the PYL2 ligand-binding pocket. The critical residues in ligand binding and the PYL2/HAB1 interface are highly conserved, suggesting that the gate-latch-lock mechanism of ligand sensing and signal transduction is likely to be used by the entire PYR/PYL/RCAR receptor family.
To prepare proteins for crystallization, the entire PYR/PYL family was expressed in Escherichia coli and screened for suitability in crystallization trials. PYR1 and PYL1-6 were soluble and yielded high levels of purified proteins ( Supplementary Fig. 1a ). Each of these family members was capable of interacting with the ABA-signalling PP2Cs HAB1, ABI1 and ABI2 ( Supplementary Fig. 1b ). However, as suggested previously by yeast two hybrid assays 7, 8 , the PYR/PYL proteins and PP2Cs showed differential interactions in response to the presence or absence of ABA, the particular stereoisomer used, and the particular PP2C probed. These biochemical observations point to possible functional variations between family members in PP2C binding and signalling. Among the proteins expressed, PYL1 and PYL2 produced high-quality crystals of apo receptors, and PYL2 crystals diffracted better than 2.0 Å both in the absence and presence of ABA ( Supplementary Fig. 1c ). PYL2 interacted with the PP2C HAB1 in an ABA-dependent manner, and showed clear preference for the natural (1)-stereoisomer ( Fig. 1a ). PYL2 was also able to inhibit the phosphatase activity of HAB1 with an IC 50 of 0.15 mM with (1)-ABA, but with an IC 50 of 1.7 mM with the biologically less active (2)-isomer ( Fig. 1b ). This 11-fold difference in selectivity is comparable to the 19-fold selectivity shown for PYL5, another member of the PYR/PYL family 9 . The PYL1 and PYL2 structures were solved by molecular replacement starting from a model of the birch pollen allergen Bet VI (PDB code 1bv1) 14 , with the statistics of the structure refinement shown in Supplementary Table 1 .
The structures of apo-and ABA-bound PYL2 have an a-b-a2-b6-a topology and exhibit nearly identical helix-grip folds, which is a hallmark of the START protein superfamily 15 (Fig. 1c) . A dominant feature of the structure is the long carboxy-terminal a-helix enfolded by an anti-parallel b-sheet of seven strands and a2 and a3 helices. The packing interactions of these elements form the hydrophobic ligandbinding cores of START proteins. Between the C-terminal helix and the b-sheet is a large pocket of 543 Å 3 in the apo structure ( Fig. 1c ), and 480 Å 3 in the ABA-bound structure (Fig. 1d ). This pocket is surrounded by 23 residues, which are mostly hydrophobic and highly conserved ( Fig. 1f ). PYL1 and PYL2 share 51% sequence identity (Supplementary Table 2 ), and the apo-PYL1 structure resembles the apo-PYL2 structure ( Fig. 1e and Supplementary Fig. 2b ). The major differences between the apo-PYL1 and apo-PYL2 structures are seen in the relative position of their amino-terminal helices and their loop structure between b-strands 6 and 7, which is invisible in the apo-PYL1 structure. In contrast, the C-terminal a-helix and the b-strands surrounding the ligand binding pocket are highly similar.
The overall structure of the PYL2-ABA complex reveals a monomeric receptor-ligand complex with 1:1 stoichiometry. The binding mode of ABA is clearly defined by a high resolution electron density map ( Fig. 2a and Supplementary Fig. 3a ). ABA is centred in the pocket with its hydrocarbon chain and cyclohexene ring fitting snugly into the hydrophobic pocket of PYL2. The intermolecular interactions between ABA and PYL2 are shown in diagram form in Fig. 2b . Each of the three polar groups of ABA forms direct or water-mediated hydrogen bonds with the receptor. The acid head group forms a charged interaction with the side chain of K64 ( Fig. 2a) , and also forms a complex network of water-mediated hydrogen bonds with residues E98, N173 and E147 ( Fig. 2a, b , and Supplementary Fig. 3a ). The hydroxyl group from the chiral carbon also forms two water-mediated hydrogen bonds with E98 and N173. Mutations in these polar residues and several other pocket residues in PYL2 reduced its ability to bind to radio-labelled ABA, to interact with HAB1 in response to ABA, and to inhibit HAB1's PP2C activity ( Fig. 2d-f ).
The ABA-bound PYL2 structure also reveals the basis for its stereoselectivity. Figure 2c shows that the monomethyl group from the cyclohexene ring fits into a narrow pocket formed by residues F66, V87, L91, P92, F165 and V169, while the dimethyl group fits into a larger pocket formed by A93, S96 and V114. The dimethyl group flipped in the (2)-isomer would cause stereo collision between the dimethyl group and the narrow pocket that accommodates the EFVDDDHRVLSFRVVGGEHRLKNYKSVTSVNEFL 
Figure 1 | Structures of apo-PYL2, ABA-PYL2 and apo-PYL1. a, ABAdependent interaction of PYL2 with HAB1. Binding of recombinant H6GST-PYL2 to recombinant biotin-HAB1 at the indicated concentrations of (1)-and (2)-ABA was determined by AlphaScreen assays as described in Methods and in Supplementary Fig. 4a (n 5 3; error bars, s.d.). b, ABAdependent inhibition of HAB1 phosphatase activity by PYL2. Phosphate release from p S175 of 100 mM SnRK2.6 phosphopeptide was determined by colorimetric assay in the presence of recombinant HAB1 and PYL2 (n 5 3; error bars, s.d.). The IC 50 values were derived from curve fitting based on a competitive inhibitor model for the binding of ABA-bound PYL2 to HAB1 (R 2 5 0.998 for (1)-ABA and 0.997 for (2)-ABA). c, Two views of the apo-PYL2 structure with its empty ligand binding pocket shown as mesh. The gate (pink) and latch (magenta) for the ligand entry are indicated by arrows. d, Overlay of the apo (grey) and ABA-bound (green) PYL2 structures. ABA is shown as a ball model with its surrounding ligand binding pocket as mesh. The latch (magenta for apo-and cyan for ABA-bound PYL2) and the conformational change in the gate (pink and yellow in apo-and ABA-bound structures, respectively) are indicated by arrows. e, Overlay of the apo structures of PYL2 (grey) and PYL1 (yellow). f, Sequence alignment of the PYR/PYL family with secondary structure elements of PYL2 below the sequences and amino acid position of full length PYL2 above the alignment. Note that PYL2 in the crystal structure starts at position 14 relative to the full-length protein. Conserved residues are highlighted, residues within a 5 Å range of the ligand are boxed, and the gate and latch residues are noted.
monomethyl group (Fig. 2c) . Thus, the size and shape of PYL2's pocket that accommodates the cyclohexene ring, together with the specific hydrogen bonds between PYL2 and ABA, contribute to its stereo-selectivity.
Comparison of the apo-and ABA-bound PYL2 structures suggests that a gate and latch mechanism is employed in hormone binding and signal transduction. The entry of the ligand-binding pocket is surrounded by a gate-like loop between b-strands 3 and 4 (residues 89-93: SGLPA) on one side, and on the other side, a latch-like region formed by a loop between b-strands 5 and 6 (residues 119-121: HRL) ( Fig. 3a ). The positions of H119 and L121 (latch) do not change substantially between apo-and ABA-bound structures. In contrast, ABA binding induces a dramatic conformational change in the SGLPA loop, which shifts 3-9 Å away from the corresponding loop of the apo-structure ( Fig. 3a, b ), a swing that closes the ligand entry gate and seals the bound ABA molecule from exposure to the solvent.
Outside the SGLPA gate, the most dramatic change of conformation occurs at residue E118, which is the residue immediately preceding the HRL latch motif (Figs 3a and 1f ). In the apo-structure, the E118 side chain points into the pocket, a position that would prevent the closure of the SGLPA gate. In the ABA-bound structure, the E118 side chain is flipped by ,150u, so that it points outside the pocket. This creates the space required for the SGLPA gate to close onto the HRL latch, with the distance between LPA (gate) and HRL (latch) changing from 11-14 Å to 3.5-3.7 Å (Fig. 3a-c) . On closing the gate, the SGLPA loop together with the HRL residues form a new interface, which we predicted could fit into the active site of the PP2C by using molecular modelling (see Methods and Supplementary Fig. 3b ).
To validate our prediction and unravel the mechanism of PP2C inhibition by PYR/PYL proteins, we prepared a ternary complex for crystallization by mixing the purified proteins of PYL2 and HAB1 in the presence of (1)-ABA ( Supplementary Fig. 1d ). Because of the high binding affinity of PYL2 to HAB1 in the presence of (1)-ABA, (estimated to be 0.15 mM, see Supplementary Fig. 4) , the ternary complex was stable and readily formed crystals ( Supplementary Fig. 1c that diffracted better than 1.95 Å . The structure was determined by molecular replacement with the ABA-PYL2 structure and a HAB1 model built from the PPM1B structure, a human PP2C 16 . The statistics of the structure refinement are shown in Supplementary Table 1 . The overall structure of the PYL2-ABA-HAB1 complex reveals a monomeric receptor-ligand-PP2C complex with 1:1:1 stoichiometry (Fig. 4a ). The catalytic domain of HAB1 adopts a typical PP2C fold 17 , containing two five-stranded b-sheets that are sandwiched by two pairs of anti-parallel a-helices. Between the two central b-sheets, there is a small domain of one short a-helix and two anti-parallel b-strands (residues 361-412) that forms the major part of the binding interface with PYL2 ( Fig. 4a-c) . The catalytic site, which is located at the top edge of the two central b-sheets with three Mg 21 ions, is partially occupied by the bound PYL2 (Fig. 4c, d) .
The complex contains a large complementary interface of 1,820 Å 2 between the ABA-bound PYL2 and HAB1, whose intermolecular interactions are summarized in Supplementary Table 3 . Consistent with our modelling, ABA-bound PYL2 docks into the catalytic active site of HAB1 (Fig. 4d) , with the SGLPA gate packing closely with residues D243 to G246, which forms the active site loop of the PP2C. The G246D mutation in HAB1 and the corresponding residues in other group A PP2Cs are well documented to cause dominant ABA-insensitivity 18 . The distance of G246 to the SGLPA gate is only 2.8-4.0 Å , which probably explains why G246D can disrupt the PP2C/ PYR1 interaction [7] [8] [9] 19 .
Importantly, the ternary complex structure reveals several critical insights of ABA binding and signal transduction that were not predicted by our modelling studies or apparent from the PYL2-ABA complex. The most striking observation is that the indole ring of W385 of HAB1 inserts between SGPLA gate and the HRL latch. In so doing, it points into the ABA-binding pocket and makes a water-mediated hydrogen bond to the ketone group of ABA (Fig. 4e, f) . This observation therefore provides direct proof that HAB1 can serve as a co-receptor that senses the binding of ABA into the PYR/PYL receptors.
In response to the insertion of W385 of HAB1 into the ABAbinding pocket of PYL2, the SGPLA gate and the HRL latch undergo several unexpected conformational changes between the PYL2-ABA and ternary PYL2-ABA-HAB1 structures (Fig. 4g) . The most drastic changes are seen in the latch residues E118 and H119, whose Ca atoms move 4.5 Å and 1.9 Å , respectively. In both apo and ABAbound PYL2, the side chain of H119 is outside of the pocket. However, in the HAB1 complex, PYL2's H119 side chain points into the pocket and makes contacts with the dimethyl groups of ABA's cyclohexene ring. Correspondingly, the position of ABA's cyclohexene ring shifts 1.2-1.4 Å , allowing its ketone group to face directly towards the water molecule that makes a hydrogen bond with W385 of HAB1 (Fig. 4e, f) . In this configuration, W385 of HAB1 functions like a molecular lock that keeps the gate and the latch in the closed positions. This locking mechanism probably explains the higher ABA binding affinities measured for PYR/PYLs in the presence of PP2Cs 7,8 . Thus, PP2C binding modifies the PYL2-ABA contact surface and creates a water-mediated contact between ABA and PP2C.
The importance of the gate and latch loops is supported by extensive mutational data ( Fig. 2d-f ). Mutations in both the gate and latch compromised ABA-dependent HAB1 interaction and PP2C activity (H119A and R120A in Fig. 5a, b) . Additionally, it has been noted that mutations in the PP2C active site (mutations that cause the dominant ABA-insensitive phenotype, for example, G180D in ABI1, G168D in a-c, Three views of the PYL2-ABA-HAB1 complex. HAB1 is shown with its catalytic domain in yellow (Mg 21 ions as balls) and the ABA-interacting domain in green (W385 lock as a ball model). PYL2 is shown in blue and ABA as a ball model with its surrounding ligand binding pocket as mesh. d, HAB1 active site as space-filling presentation with Mg 21 ions as balls and the docking PYL2 shown as carbon backbone (gate in pink and latch in gold colour). e, HAB1 W385 docking into a PYL2 cavity enables it to make a water-mediated interaction with the ketone group of ABA. The loop containing W385 is shown as ribbon in cyan. f, Network of water-mediated interactions with the ketone group of ABA in the PYL2-ABA-HAB1 complex. ABA and key residues are shown with the surrounding electron density map (2F o 2 F c ) contoured at 1s, W385 of HAB1 is highlighted in yellow. g, HAB1 docking induces conformational changes in the PYL2 gate and latch. Close-up overlay view of PYL2-ABA in the presence (blue) and absence (green) of HAB1. The latch is shown in cyan (2HAB1) and gold (1HAB1), the gate in yellow (2HAB1) and pink (1HAB1), and ABA in grey (2HAB1) and peach (1HAB1).
ABI2, and G246D in HAB1) disrupt PP2C's interaction with PYR1 (refs 7-9, 19), which is consistent with our model, as the larger side chain of the mutated residues would collide with the SGPLA gate ( Supplementary Fig. 3c ). Furthermore, the direct docking of PYL2's SGPLA loop into the active site of HAB1 indicates that the ABAbound PYL2 functions as a competitive inhibitor of PP2Cs. To test this prediction, we investigated whether increasing concentrations of a PP2C substrate, a SnRK2.6 peptide containing residues 170-180 and a phosphorylated serine at position 175, could overcome the inhibition of HAB1 PP2C activity by ABA-bound PYL2 (Fig. 5c ). SnRK2.6 is a natural substrate of PP2C, and phosphorylation at S175 is required for SnRK2.6 kinase activation and its role in ABA signalling 5 . Our results are consistent with a competitive inhibitor mechanism between ABAbound PYL2 and the PP2C active site (Figs 4d and 5c ). Thus, our structures illuminate both the mode of ligand binding and PP2C inhibition.
To validate the functional roles of the PYL2/HAB1 interface in ABA signalling, we mutated key residues that form the gate and latch of PYL2, and analysed their function in protoplasts 20 , where ABAinduction of gene expression can be reconstituted by coexpression of a PYR/PYL protein, PP2Cs, SnRK2 kinases, the ABF2 transcription factor and an ABA-responsive promoter reporter construct 11 . Using this system, ABA induces reporter gene activation in the presence of PYL2, HAB1, SnRK2.6 and ABF2 (Fig. 5d ). However, mutations in PYL2 residues involving ligand binding or formation of the gate and latch compromise the ability of PYL2 to activate the reporter in response to ABA. These mutations also reduced the ability of PYL2 function through ABI1 ( Supplementary Fig. 5 ). Thus, our mutational and structural data indicate that the gate and latch residues involved in conformational changes are critical components of the information transfer mechanism.
The 14 members of the PYR/PYL family share 38-84% sequence identity over the entire length of the proteins (Supplementary Table 2 ), but the SGLPA and HRL sequences are invariant among the PYR/PYL family members (Fig. 1f ), suggesting that the gate and latch mechanism is likely to be a common feature of these receptors. To further investigate this mechanism and ascertain if it is used by other family members, we studied the consequences of ABA binding on PYR1 using the HSQC (heteronuclear single quantum coherence) NMR technique, which is a complementary method because it enables measurements of dynamics directly in solution. PYR1 was chosen as a model because its HSQC NMR spectra have been previously investigated 7 . ABA binding induced either exchange broadening or chemical shift perturbation in residues surrounding the ligand binding pocket ( Supplementary Fig. 6a ). In contrast, the vast majority (66 of 71, 93%) of unperturbed residues in the PYR1 spectrum are located outside the ABA binding pocket ( Supplementary Fig. 6b) . Notably, the SGLPA gate and the HRL latch residues exhibit broadening or large shift perturbation, consistent with a large conformational change on ligand binding (Supplementary Fig. 6c, d) . Thus, the chemical shift perturbations induced by ABA binding to PYR1, collected by solution NMR, correlate exceedingly well with the molecular interactions observed in the crystal structures of apo-and ABA-bound PYL2. These observations strongly argue that conformational dynamics accompany ligand binding in multiple PYR/ PYL family members, and strengthen our conclusion that they are central to the mechanism of signal transduction.
We also performed transgenic plant studies of PYR1 with a mutated latch residue (H115A). The homologous residue (H119) in PYL2 is pointed outward to the solvent in both the apo-and ABA-bound PYL2 structures (Fig. 3a, b) , thus the H115A mutation is predicted not to interfere with ABA binding in the absence of HAB1. Indeed, NMR spectra of 15 N-labelled PYR1H115A show that the mutated protein forms a stably folded protein that responds to ABA similarly to the wild-type PYR1 (Fig. 6a) , indicating that the H115A PYR1 has comparable ligand binding capability to the wild type in the absence of HAB1. However, consistent with the important role of this latch residue in ABA binding in the PYL2/PP2C complex, the H115A PYR1 protein was defective in ABA-mediated PP2C inhibition in vitro ( Fig. 6b ) and was not able to interact with HAB1 in response to (1)-ABA ( Fig. 6c ). Furthermore, H115A PYR1 failed to rescue the ABA-response defect of a quadruple pyr1/pyl1/pyl2/pyl4 mutant in transgenic plants, whereas the wild-type PYR1 did (Fig. 6d ). Together, these results demonstrate that the latch residue H115 is not important for ligand binding in the context of PYR1 itself, but is critical for the receptor to relay the ABA binding signal to PP2Cs and downstream signalling effectors.
In this paper, we present four crystal structures involving two ABA receptors, PYL1 and PYL2, in apo-forms, and the ABA-bound forms of PYL2, either alone or in complex with the HAB1 PP2C. In combination with biochemical, mutagenesis, NMR, and transgenic plant studies, our structures highlight a gate-latch-lock mechanism of ABA binding and signalling by the PYR/PYL family and PP2Cs. The ternary complex structure reveals that PP2Cs can function as co-receptors to facilitate the interaction of PYR/PYL proteins with ABA, and establish that these proteins together are bona fide ABA receptors that transduce plant stress signals. Elucidation of the structures and mechanisms of these core components of ABA signalling pathways will help construct a rational framework for understanding plant stress biology as well as for engineering plants that are resistant to salt and drought environments.
The START domain was originally identified in proteins involved in steroidogenesis and metabolism in metazoans [21] [22] [23] . Although members of the START domain family continue to be identified 15, 24 , the cellular functions of most START proteins still remain elusive beyond the established roles in transfer of lipids and cholesterol for a few members 25 . Identification of the gate-latch-lock mechanism for hormone binding and signalling by ABA receptors suggests that other members in the large family of START domain proteins may also function as ligand sensing and signal transduction molecules like ABA receptors.
METHODS SUMMARY
PYL2, PYL1 and HAB1 were expressed as 63His-GST (H6GST) or H6SUMO fusion proteins in E. coli. Proteins were purified by Ni-NTA chromatography, followed by proteolytic release of tags and size-exclusion chromatography. For formation of PYL2-ABA and HAB1-PYL2-ABA complexes, ABA was mixed with PYL2 and HAB1-PYL2 at 5:1 ratios. Crystals were grown by vapour diffusion and diffraction data were collected from cryo-protected crystals at beamlines 21-ID-D and 21-ID-F at the Advanced Photon Source at Argonne National Laboratories. Structures were solved by molecular replacement in PHASER 26 using the structure of the plant START protein Bet v 1 as model for PYL2 and the structure of the human PP2C PPM1B as model for HAB1. Models were manually fitted using O and Coot 27,28 and further refined using CNS and Refmac5 29, 30 .
Mutant proteins were expressed as H6GST-fusion proteins and purified by glutathione sepharose chromatography. Protein-protein interactions were determined by luminescence proximity AlphaScreen assay and by yeast twohybrid assay. Biotinylated HAB1 for the luminescence proximity assay was generated by in vivo biotinylation of an avitag-HAB1 fusion protein. ABA binding was determined by scintillation proximity assay using 3 H-labelled ABA. HAB1 phosphatase activity was measured by phosphate release from a SnRK2.6 phosphoprotein (Figs 1-5) or from a generic pNPP phosphate substrate (Fig. 6b) .
For transgenic studies, wildtype and mutant 35S::GFP-PYR1 constructs were transformed by the floral dip method into pyr1/pyl1/pyl2/pyl4 quadruple mutants. Mutant complementation of GFP 1 seedlings was assayed by root length measurements. The ABA signal transduction pathway was reconstituted in protoplasts by transient transfection of PYL2, PP2C, SnRK2.6 and ABF2 expression plasmids. Activation of an ABA-inducible RD29B promoter-LUC reporter by PYL2 mutant proteins was determined by luciferase assays normalized for b-glucuronidase activity from a UQ10-GUS reporter. . c, The H115A PYR1 mutant is defective in ABA-mediated HAB1 interaction, as shown by yeast two-hybrid assay. AD, activation domain; BD, DNA binding domain. d, The H115A PYR1 mutant is defective in inhibiting the root growth of transgenic plants in response to ABA. A quadruple pyr1/pyl1/pyl2/pyl4 mutant (Q) defective in root growth inhibition can be complemented by wild-type PYR1, but not by PYR1 (H115A) (n 5 6-10; error bars, s.d.).
